---
document_datetime: 2023-09-21 21:06:45
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/dasselta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: dasselta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.9217649
conversion_datetime: 2025-12-19 11:59:16.778655
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Dasselta

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                             |
|----------------------|-------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/962/ 202107    | Periodic Safety Update EU Single assessment - desloratadine | 24/03/2022                          | 30/05/2022                                  | SmPC and PL                      | Please refer to Aerius-Azomyr-Neoclarityn-Desloratadine Teva-Dasselta-Desloratadine Actavis-Desloratadine ratiopharm-EMEA/H/C/PSUSA/00000962/202107 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| IA/0020/G            | This was an application for a group of variations.          | 05/10/2021                          | n/a                                         |                                  |                                                                                                                                                                                                                                                                     |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                   | deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer   |            |            |                                  |                                                                                                                        |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------|
| N/0019            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                               | 17/05/2021 | 30/05/2022 | PL                               |                                                                                                                        |
| IB/0018           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                   | 07/05/2020 | 30/04/2021 | SmPC, Annex II, Labelling and PL |                                                                                                                        |
| IB/0017           | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                      | 12/03/2018 | 07/02/2019 | SmPC                             |                                                                                                                        |
| IB/0016           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                 | 07/02/2018 | 07/02/2019 | SmPC, Labelling and PL           |                                                                                                                        |
| PSUSA/962/2 01607 | Periodic Safety Update EU Single assessment - desloratadine                                                                                                                                                                                                                                                                                                                                                                                    | 23/03/2017 | 18/05/2017 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |                                  | PSUSA/962/201607.                                                                                                                                                                                                                                                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0015/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 05/04/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                        |
| IAIN/0014 | B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                                                                                                                                                                                                                                                                           | 15/03/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                        |
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/06/2016 | 16/08/2016 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Dasselta in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IA/0010   | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                                               | 15/02/2016 | n/a        |                                  |                                                                                                                                                                                                                                                                        |
| IA/0011   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                            | 12/02/2016 | n/a        |                                  |                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

| IB/0009   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                 | 07/10/2015   | 21/04/2016   | SmPC and PL   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|
| IB/0008   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                 | 11/06/2015   | 21/04/2016   | SmPC and PL   |
| IB/0007/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 28/04/2015   | 21/04/2016   | SmPC and PL   |
| IB/0005/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 05/03/2015   | n/a          |               |

<div style=\"page-break-after: always\"></div>

|           | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data   |            |            |                                  |                                                                                                                                                                                                         |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0006 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                       | 26/02/2015 | n/a        |                                  |                                                                                                                                                                                                         |
| IB/0004   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                             | 12/09/2013 | 22/08/2014 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                         |
| N/0003    | Update of the local representatives contact details in the package leaflet and inclusion of an additional local representative of the Marketing Authorisation Holder for the new Croatian Member State. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                              | 02/07/2013 | 22/08/2014 | PL                               | Update of the local representatives contact details in the package leaflet and inclusion of an additional local representative of the Marketing Authorisation Holder for the new Croatian Member State. |
| IA/0002   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS                                                                                                                                                 | 22/10/2012 | n/a        |                                  |                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

| N/0001   | Updated local representative contact details for Ireland, Malta and Spain. The MAH also made editorial changes in the Bulgarian, Spanish and French package leaflets and for the labelling in Denmark.   | 13/03/2012   | 22/08/2014   | Labelling and PL   | Minor change in labelling   |
|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------|-----------------------------|